I sat down the Founder of Qvin to explore a groundbreaking device that uses menstrual blood to monitor biomarkers for conditions like cervical cancer, fertility, thyroid health, STIs, and more. Already making waves, Qvin’s FDA-cleared test for A1C measures average blood glucose over three months using a pad-like device during a menstrual cycle, with results sent to a smartphone app. We dive into how this innovation is transforming early diagnostics, its current use for cervical cancer screening in Southeast Asia, and Dr. Naser’s journey—from developing a molecule to block skin cancer to simulating cycles with a robot named Betty.

DISCLAIMERS: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Revolutionizing A1C and Biomarker Testing with the Q-Pad